Mumbai: Thyrocare Technologies Limited (hereinafter referred to as “Thyrocare”, a healthcare diagnostics company, has announced the appointment of Rajdeep Panwar as its Chief Commercial Officer (CCO). The move strengthens Thyrocare’s leadership team as the company sharpens its commercial strategy and customer focus across India.
Panwar is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostics sector. He brings extensive experience in P&L management, multi-market business expansion, strategic planning, and scaling large multi-centre diagnostic operations. Over the course of his career, he has been involved in the launch and management of more than 200 diagnostic laboratories and has been a founding team member of two healthcare ventures.
Prior to joining Thyrocare, Panwar served as Director at GHL Pharma & Diagnostics Ltd. (GHL–Medanta), where he played a key role in expanding Medanta Labs across North India. His professional journey also includes leadership roles at Apollo Diagnostics, Johnson & Johnson, and Dr. Lal PathLabs, where he led initiatives spanning business expansion, commercial strategy, technical operations, customer support, process excellence, accreditation, and organisational transformation.
Commenting on his appointment, Rajdeep Panwar, Chief Commercial Officer, Thyrocare, said, “I am excited to join Thyrocare at a pivotal phase of its growth. The company’s mission to make high-quality diagnostics affordable and accessible across India strongly resonates with me. With its deep partner network and strong scientific foundation, Thyrocare is well positioned to get closer to patients and drive meaningful impact at scale.”
Rahul Guha, Managing Director and CEO of API Holdings, added, “As Thyrocare continues to scale, strengthening our leadership team is critical, and particularly having strong commercial leadership is key. Rajdeep brings deep experience in building and expanding diagnostics businesses in India. We believe his leadership will help strengthen our market approach and deepen engagement with customers and partners. In combination with Dr. Kinha, who recently joined us as Chief Operating Officer (COO) and brings deep operational and quality expertise, the Thyrocare leadership team is best in class and well positioned to win in this growing market.”
In his new role, Panwar will be responsible for the P&L of Thyrocare and will lead the company’s commercial functions end-to-end, including franchise business, corporate business, direct-to-consumer channels, customer relationship management, customer operations, catalogue management, and radiology services. He will focus on driving revenue growth, enhancing customer experience, and expanding Thyrocare’s footprint across India.
Panwar’s appointment underscores Thyrocare’s commitment to building a leadership team capable of delivering on its growth ambitions. As part of API Holdings, Thyrocare remains focused on its core mission of making healthcare more accessible through diagnostics that are both affordable and accurate.
